Ernst Wagner is an expert in Biochemistry at Ludwig-Maximilians-Universität München (Germany). As of October 2026, ScienceLeadR ranks Ernst Wagner in the top 1% of experts worldwide for Technology, Pharmaceutical. Ernst Wagner has authored 380 publications, the most recent in 2026. SLR score: 1,245 (community average: 125). How the SLR is computed.

LeadR Profile

1 245 ScienceLeadR Reputation 1245
Network Map

Biochemistry

Subspecialties: Pharmacy - Genetics - Oncology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1982 - 2026

Source: PubMed

Ludwig-Maximilians-Universität München

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 380

Citations

Citations: 18 789 1st author: 10 Last author: 147 Unique author: 18


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
mRNA Delivery by Lipoamino Fatty Acid-Peptide Polyplexes in Different Lung Cell Models and Lungs.
PMID 42280578 — cells, lung, hyaluronic acid, nanoparticles, rna, messenger, therapeutics, transfection, fatty acids
Polymers (Basel)20260
Poly(I:C) Lipoamino Bundle LNPs Induce Tumor Cytotoxicity and Immune Activation with Enhanced Efficacy by Survivin Silencing.
PMID 42278494 — cells, survivin, neoplasms, multiple chronic conditions, therapeutics, lipid nanoparticles
Int J Mol Sci20260
Spatiotemporal Nanotransformers for Antitumoral Orchestration of Protein Homeostasis.
PMID 42253773 — homeostasis
Polym Sci Technol20260
Enhanced Intramuscular mRNA Activity of Peptide-Lipid Nanoparticles with Hydrophobized Head Groups.
PMID 42179174 — biochemistry, nanoparticles, rna, messenger, lipid nanoparticles
Bioconjug Chem20260
Development of CAR NK Cell Lines Selectively Targeting Cancer Cells Expressing Membrane Hsp70.
PMID 42125069 — cells, killer cells, natural, neoplasms, immunotherapy, squamous cell carcinoma of head and neck, cell line, therapeutics, membranes
MedComm (2020)20260

LeadR Networks

Main global connection map